Stock data

豪展 (4735)

豪展 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$100.79M, up 37.0% from a year earlier. EPS over the last four quarters totals NT$6.03.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 豪展 in Insightr